Boston-based a2z Radiology raised $4.5M and earned FDA clearance for its Unified Triage AI solution for abdominal and pelvic CT scans.
Key Details
- 1a2z Radiology, founded in 2024, is developing AI tools for medical imaging interpretation.
- 2The company secured $4.5 million in seed funding from investors including SeaX and Khosla Ventures.
- 3Its Unified Triage system received FDA clearance and is designed as a multi-condition tool for abdomen-pelvis CT analysis.
- 4a2z claims its product is the first of its kind, focusing on broad multi-condition triage instead of single findings.
- 5The funds will be used to commercially deploy Unified Triage and develop further imaging AI products.
- 6Harvard biomedical informatics professor Pranav Rajpurkar co-founded the startup.
Why It Matters
Multi-condition AI tools could streamline radiology workflows, helping to detect a broader range of pathologies in a single scan and supporting radiologist efficiency. Regulatory milestones and investment indicate escalating momentum for generalist AI in medical imaging.
Source
Radiology Business
Related News
•HealthExec
New Report Highlights Clinical AI Performance, Sustainability, and Adoption Challenges
A multi-institutional review details key challenges, progress, and sustainability concerns in deploying clinical AI in real-world healthcare settings.
•Cardiovascular Business
FDA Clears AI Platform for Comprehensive Cardiac Risk Assessment on CT
HeartLung Corporation's AI-CVD receives FDA clearance for opportunistic multi-condition screening on routine chest CT scans.
•AuntMinnie
LLM Boosts Terminology Expansion in Radiology Reports Over RadLex
A large language model (LLM) significantly outperforms RadLex in expanding terms for radiology report language standardization.